MAST CELL DEGRANULATING PEPTIDE manufacturers
|
| MAST CELL DEGRANULATING PEPTIDE Basic information |
Product Name: | MAST CELL DEGRANULATING PEPTIDE | Synonyms: | H-ILE-LYS-+CYS-ASN-++CYS-LYS-ARG-HIS-VAL-ILE-LYS-PRO-HIS-ILE-+CYS-ARG-LYS- ILE-++CYS-GLY-LYS-ASN-NH2;H-ILE-LYS-CYS-ASN-CYS-LYS-ARG-HIS-VAL-ILE-LYS-PRO-HIS-ILE-CYS-ARG-LYS-ILE-CYS-GLY-LYS-ASN-NH2;H-ILE-LYS-CYS-ASN-CYS-LYS-ARG-HIS-VAL-ILE-LYS-PRO-HIS-ILE-CYS-ARG-LYS-ILE-CYS-GLY-LYS-ASN-NH2 (RANDOM CYCLIZATION);IKCNCKRHVIKPHICRKICGKN-NH2;ILE-LYS-CYS-ASN-CYS-LYS-ARG-HIS-VAL-ILE-LYS-PRO-HIS-ILE-CYS-ARG-LYS-ILE-CYS-GLY-LYS-ASN-NH2;MAST CELL DEGRANULATING PEPTIDE;MAST CELL DEGRANULATING PEPTIDE (APIS MELLIFERA);MAST CELL DEGRANULATING (MCD) PEPTIDE | CAS: | 32908-73-9 | MF: | C110H192N40O24S4 | MW: | 2587.24 | EINECS: | | Product Categories: | | Mol File: | 32908-73-9.mol | |
| MAST CELL DEGRANULATING PEPTIDE Chemical Properties |
density | 1.50±0.1 g/cm3(Predicted) | storage temp. | −20°C | solubility | Soluble in DMSO |
WGK Germany | 3 | RTECS | OQ5980000 |
| MAST CELL DEGRANULATING PEPTIDE Usage And Synthesis |
Biological Activity | Peptide 401 is a potent mast cell degranulation peptide derived from bee venom that inhibits vascular permeability. | in vivo | Peptide 401 substantially inhibits the oedema provoked by subplantar injection of carrageenin or intra-articular injection of turpentine in the rat. The ED 50 of 401 is c. 0.1 mg/kg. The anti-inflammatory effect is assessed by measurement of the increased 125 I-albumin content of an injected site in comparison with an uninjected contralateral site. Peptide 401 also suppresses the increased vascular permeability due to intradermal injection of various smooth muscle spasmogens (histamine, bradykinin, 5-hydroxytryptamine (5-HT), and prostaglandins). Peptide 401 (MCD peptide) contains 22 residues and occurs in the venom of the common European honey bee to the extent of about 2% by weight . It has powerful anti-inflammatory activity (at doses as low as 0.1 mg/kg) in a variety of animal models, ie, hind paw oedema in the rat induced by carrageenin or turpentine, adjuvant arthritis in the rat, and increased skin permeability in the rat resulting from subcut aneous injection of bradykinin, prostaglandin E1 kallikrein, histamine and 5-hydroxytryptamine (5-HT). It has a powerful degranulating effect on mast cells and involves the release of histamine and other pharmacologically active agents. | target | serotonin | Histamine Receptor | < /table>
| MAST CELL DEGRANULATING PEPTIDE Preparation Products And Raw materials |
|
Tag:MAST CELL DEGRANULATING PEPTIDE(32908-73-9)
Related Product Information
|
3':5'-CYCLIC-NUCLEOTIDE 5'-NUCLEOTIDOHYDROLASE
ECHISTATIN
PHOSPHOLIPASE A2
MASTOPARAN 17
VAL-ASP-TRP-LYS-LYS-ILE-GLY-GLN-HIS-ILE-LEU-SER-VAL-LEU-NH2
MU-CONOTOXIN GIIIA
Desacetylcinobufagin
19-Hydroxybufalin
MAS 7
MAST CELL DEGRANULATING PEPTIDE HR-1
MAST CELL DEGRANULATING PEPTIDE HR-2
ENTEROTOXIN STP (E COLI)
CHLOROTOXIN
SHK
NA
CYS-GLY
MAST CELL DEGRANULATING PEPTIDE
MAST CELL DEGRANULATING PEPTIDE
|
According to the laws, regulations and policies related to "patent products", the sale of this product is prohibited!
ChemicalBook prompt
The patent owner or licensee of the product has not released any relevant information for the time being.
|